E Fund Management Co., Ltd.

Position in RYTM — Rhythm Pharmaceuticals, Inc.

CIK 1842296 GUANGZHOU, F4

Position in RYTM

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$527,503

-$33,714 QoQ

Shares Held

4,751

-26.4% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#186

of 299 holders

Holding Since

Sep 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

E Fund Management Co., Ltd. holds $66,079,043 across 109 Biotechnology names. RYTM ranks #18 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	11,455	$5,690,042
2	ERAS	Erasca, Inc.	265,381	$4,861,779
3	CELC	Celcuity Inc.	45,895	$4,801,534
4	EYPT	EyePoint, Inc.	330,774	$4,730,068
5	AVBP	ArriVent BioPharma, Inc.	109,328	$3,798,054
6	REGN	Regeneron Pharmaceuticals, Inc.	5,158	$3,216,219
7	LEGN	Legend Biotech Corp	109,327	$3,157,363
8	ALNY	Alnylam Pharmaceuticals, Inc.	6,073	$1,828,155

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$527,503	4,751	-26.4%	Shares	Defined	2026-08-11
2026-03-31	$561,217	6,453	+12.0%	Shares	Defined	2026-04-13
2025-06-30	$364,037	5,761	+6.8%	Shares	Sole	2025-08-15
2025-03-31	$285,826	5,396	+30.1%	Shares	Sole	2025-05-13
2024-09-30	$217,366	4,149	-59.8%	Shares	Sole	2024-11-13
2024-03-31	$447,728	10,333	+58.2%	Shares	Sole	2024-05-13
2023-12-31	$300,322	6,533	-53.2%	Shares	Sole	2024-02-07
2023-06-30	$230,002	13,948	-3.7%	Shares	Sole	2023-08-11
2023-03-31	$258,394	14,484	-9.8%	Shares	Sole	2023-05-11
2022-12-31	$467,550	16,056	-11.0%	Shares	Sole	2023-02-14
2022-09-30	$441,857	18,035	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.